Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2006-11-21 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: DANNEMARIE (68210), Haut-Rhin
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE LA PORTE D'ALSACE : revenue, balance sheet and financial ratios
PHARMACIE DE LA PORTE D'ALSACE is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in DANNEMARIE (68210),
this company of category PME
shows in 2021 a revenue of 4.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA PORTE D'ALSACE (SIREN 492977905)
Indicator
2023
2022
2021
Revenue
N/C
N/C
4 897 535 €
Net income
297 067 €
380 413 €
315 884 €
EBITDA
N/C
N/C
446 303 €
Net margin
N/C
N/C
6.4%
Revenue and income statement
In 2023, PHARMACIE DE LA PORTE D'ALSACE generates positive net income of 297 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2021-2023: 316 k€ -> 297 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
297 067 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 67%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
26.521%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
66.65%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA PORTE D'ALSACE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
Debt ratio
15.494
11.737
26.521
Financial autonomy
74.102
74.608
66.65
Repayment capacity
0.938
None
None
Cash flow / Revenue
6.424%
None%
None%
Sector positioning
Debt ratio
26.522023
2021
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good
In 2023, the debt ratio of PHARMACIE DE LA PORTE D'A... (26.52) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
66.65%2023
2021
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good
In 2023, the financial autonomy of PHARMACIE DE LA PORTE D'A... (66.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.94 years2021
2021
Q1: 1.06 years
Med: 3.56 years
Q3: 7.31 years
Excellent
In 2021, the repayment capacity of PHARMACIE DE LA PORTE D'A... (0.94) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 164.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
164.807
Liquidity indicators evolution PHARMACIE DE LA PORTE D'ALSACE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2021
2022
2023
Liquidity ratio
96.392
153.617
164.807
Interest coverage
3.862
None
None
Sector positioning
Liquidity ratio
164.812023
2021
2022
2023
Q1: 135.25
Med: 189.78
Q3: 270.35
Average+21 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE LA PORTE D'A... (164.81) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
3.86x2021
2021
Q1: 0.27x
Med: 2.43x
Q3: 5.92x
Good
In 2021, the interest coverage of PHARMACIE DE LA PORTE D'A... (3.9x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 192 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 842 days. Excellent situation: suppliers finance 650 days of the operating cycle (retail model).
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
192 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
842 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA PORTE D'ALSACE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2021
2022
2023
Operating WCR
323 678 €
0 €
0 €
Inventory turnover (days)
21
0
0
Customer payment term (days)
8
127
192
Supplier payment term (days)
39
925
842
Positioning of PHARMACIE DE LA PORTE D'ALSACE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE LA PORTE D'ALSACE is estimated at
3 505 234 €
(range 2 131 701€ - 4 927 573€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
2131k€3505k€4927k€
3 505 234 €Range: 2 131 701€ - 4 927 573€
NAF 5 année 2023
Valuation method used
Net Income Multiple
297 067 €
×
11.8x
=3 505 235 €
Range: 2 131 701€ - 4 927 574€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA PORTE D'ALSACE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA PORTE D'ALSACE
What is the revenue of PHARMACIE DE LA PORTE D'ALSACE ?
The revenue of PHARMACIE DE LA PORTE D'ALSACE in 2021 is 4.9 M€.
Is PHARMACIE DE LA PORTE D'ALSACE profitable?
Yes, PHARMACIE DE LA PORTE D'ALSACE generated a net profit of 297 k€ in 2023.
Where is the headquarters of PHARMACIE DE LA PORTE D'ALSACE ?
The headquarters of PHARMACIE DE LA PORTE D'ALSACE is located in DANNEMARIE (68210), in the department Haut-Rhin.
Where to find the tax return of PHARMACIE DE LA PORTE D'ALSACE ?
The tax return of PHARMACIE DE LA PORTE D'ALSACE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA PORTE D'ALSACE operate?
PHARMACIE DE LA PORTE D'ALSACE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart